AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: TACKET CO MASON HS LOSONSKY G CLEMENTS JD LEVINE MM ARNTZEN CJ
Citation: Co. Tacket et al., IMMUNOGENICITY IN HUMANS OF A RECOMBINANT BACTERIAL-ANTIGEN DELIVEREDIN A TRANSGENIC POTATO, Nature medicine, 4(5), 1998, pp. 607-609

Authors: TACKET CO TAYLOR RK LOSONSKY G LIM Y NATARO JP KAPER JB LEVINE MM
Citation: Co. Tacket et al., INVESTIGATION OF THE ROLES OF TOXIN-COREGULATED PILI AND MANNOSE-SENSITIVE HEMAGGLUTININ PILI IN THE PATHOGENESIS OF VIBRIO-CHOLERAE O139 INFECTION, Infection and immunity, 66(2), 1998, pp. 692-695

Authors: DONNENBERG MS TACKET CO LOSONSKY G FRANKEL G NATARO JP DOUGAN G LEVINE MM
Citation: Ms. Donnenberg et al., EFFECT OF PRIOR EXPERIMENTAL HUMAN ENTEROPATHOGENIC ESCHERICHIA-COLI INFECTION ON ILLNESS FOLLOWING HOMOLOGOUS AND HETEROLOGOUS RECHALLENGE, Infection and immunity, 66(1), 1998, pp. 52-58

Authors: TAYLOR DN TACKET CO LOSONSKY G CASTRO O GUTIERREZ J MEZA R NATARO JP KAPER JB WASSERMAN SS EDELMAN R LEVINE MM CRYZ SJ
Citation: Dn. Taylor et al., EVALUATION OF A BIVALENT (CVD-103-HGR CVD-111) LIVE ORAL CHOLERA VACCINE IN ADULT VOLUNTEERS FROM THE UNITED-STATES AND PERU, Infection and immunity, 65(9), 1997, pp. 3852-3856

Authors: TACKET CO KELLY SM SCHODEL F LOSONSKY G NATARO JP EDELMAN R LEVINE MM CURTISS R
Citation: Co. Tacket et al., SAFETY AND IMMUNOGENICITY IN HUMANS OF AN ATTENUATED SALMONELLA-TYPHIVACCINE VECTOR STRAIN EXPRESSING PLASMID-ENCODED HEPATITIS-B ANTIGENSSTABILIZED BY THE ASD-BALANCED LETHAL VECTOR SYSTEM (VOL 65, PG 3383,1997), Infection and immunity, 65(9), 1997, pp. 3981-3981

Authors: TACKET CO KELLY SM SCHODEL F LOSONSKY G NATARO JP EDELMAN R LEVINE MM CURTISS R
Citation: Co. Tacket et al., SAFETY AND IMMUNOGENICITY IN HUMANS OF AN ATTENUATED SALMONELLA-TYPHIVACCINE VECTOR STRAIN EXPRESSING PLASMID-ENCODED HEPATITIS-B ANTIGENSSTABILIZED BY THE ASD-BALANCED LETHAL VECTOR SYSTEM, Infection and immunity, 65(8), 1997, pp. 3381-3385

Authors: MICHETTI P KREISS C KOTLOFF K PORTA N BLANCO JL BACHMANN D SALDINGER PF CORTHESYTHEULAZ I LOSONSKY G NICHOLS R STOLTE M MONATH T ACKERMAN S BLUM AL
Citation: P. Michetti et al., ORAL IMMUNIZATION OF HELICOBACTER-PYLORI INFECTED ADULTS WITH RECOMBINANT UREASE AND LT ADJUVANT, Gastroenterology, 112(4), 1997, pp. 1042-1042

Authors: TACKET CO KOTLOFF KL LOSONSKY G NATARO JP MICHALSKI J KAPER JB EDELMAN R LEVINE MM
Citation: Co. Tacket et al., VOLUNTEER STUDIES INVESTIGATING THE SAFETY AND EFFICACY OF LIVE ORAL EL-TOR VIBRIO-CHOLERAE-01 VACCINE STRAIN CVD-111, The American journal of tropical medicine and hygiene, 56(5), 1997, pp. 533-537

Authors: NORIEGA FR LOSONSKY G LAUDERBAUGH C LIAO FM WANG JY LEVINE MM
Citation: Fr. Noriega et al., ENGINEERED DELTA-GUAB-A DELTA-VIRG SHIGELLA-FLEXNERI 2A STRAIN CVD-1205 - CONSTRUCTION, SAFETY, IMMUNOGENICITY, AND POTENTIAL EFFICACY AS AMUCOSAL VACCINE, Infection and immunity, 64(8), 1996, pp. 3055-3061

Authors: BARRY EM GOMEZDUARTE O CHATFIELD S RAPPUOLI R PIZZA M LOSONSKY G GALEN J LEVINE MM
Citation: Em. Barry et al., EXPRESSION AND IMMUNOGENICITY OF PERTUSSIS TOXIN S1 SUBUNIT-TETANUS TOXIN FRAGMENT-C FUSIONS IN SALMONELLA-TYPHI VACCINE STRAIN CVD-908, Infection and immunity, 64(10), 1996, pp. 4172-4181

Authors: NORIEGA FR LOSONSKY G WANG JY FORMAL SB LEVINE MM
Citation: Fr. Noriega et al., FURTHER CHARACTERIZATION OF DELTA-AROA DELTA-VIRG SHIGELLA-FLEXNERI 2A STRAIN CVD-1203 AS A MUCOSAL SHIGELLA VACCINE AND AS A LIVE-VECTOR VACCINE FOR DELIVERING ANTIGENS OF ENTEROTOXIGENIC ESCHERICHIA-COLI, Infection and immunity, 64(1), 1996, pp. 23-27

Authors: TACKET CO LOSONSKY G NATARO JP WASSERMAN SS CRYZ SJ EDELMAN R LEVINE MM
Citation: Co. Tacket et al., EXTENSION OF THE VOLUNTEER CHALLENGE MODEL TO STUDY SOUTH-AMERICAN CHOLERA IN A POPULATION OF VOLUNTEERS PREDOMINANTLY WITH BLOOD-GROUP ANTIGEN-O, Transactions of the Royal Society of Tropical Medicine and Hygiene, 89(1), 1995, pp. 75-77

Authors: TACKET CO LOSONSKY G NATARO JP COMSTOCK L MICHALSKI J EDELMAN R KAPER JB LEVINE MM
Citation: Co. Tacket et al., INITIAL CLINICAL-STUDIES OF CVD-112 VIBRIO-CHOLERAE O139 LIVE ORAL VACCINE - SAFETY AND EFFICACY AGAINST EXPERIMENTAL CHALLENGE, The Journal of infectious diseases, 172(3), 1995, pp. 883-886

Authors: LAGOS R AVENDANO A PRADO V HORWITZ I WASSERMAN S LOSONSKY G CRYZ S KAPER JB LEVINE MM
Citation: R. Lagos et al., ATTENUATED LIVE CHOLERA VACCINE STRAIN CVD-103-HGR ELICITS SIGNIFICANTLY HIGHER SERUM VIBRIOCIDAL ANTIBODY-TITERS IN PERSONS OF BLOOD-GROUP-O, Infection and immunity, 63(2), 1995, pp. 707-709

Authors: HUQ A HASAN JAK LOSONSKY G DIOMIN V COLWELL RR
Citation: A. Huq et al., COLONIZATION OF PROFESSIONAL DIVERS BY TOXIGENIC VIBRIO-CHOLERAE O1 AND VIBRIO-CHOLERAE NON-O1 AT DIVE SITES IN THE UNITED-STATES, UKRAINE AND RUSSIA, FEMS microbiology letters, 120(1-2), 1994, pp. 137-142

Authors: TACKET CO REID RH BOEDEKER EC LOSONSKY G NATARO JP BHAGAT H EDELMAN R
Citation: Co. Tacket et al., ENTERAL IMMUNIZATION AND CHALLENGE OF VOLUNTEERS GIVEN ENTEROTOXIGENIC ESCHERICHIA-COLI CFA II ENCAPSULATED IN BIODEGRADABLE MICROSPHERES/, Vaccine, 12(14), 1994, pp. 1270-1274

Authors: CARILLO L GILMAN RH MANTLE RE NUNEZ N WATANABE J MORON J QUISPE V RAMIREZRAMOS A CABALLERO J VILLAREALL J COLWELL R LOSONSKY G HASAN J LOOMIS L
Citation: L. Carillo et al., RAPID DETECTION OF VIBRIO-CHOLERAE O1 IN STOOLS OF PERUVIAN CHOLERA PATIENTS BY USING MONOCLONAL IMMUNODIAGNOSTIC KITS, Journal of clinical microbiology, 32(3), 1994, pp. 856-857

Authors: GONZALEZ C HONE D NORIEGA FR TACKET CO DAVIS JR LOSONSKY G NATARO JP HOFFMAN S MALIK A NARDIN E SZTEIN MB HEPPNER DG FOUTS TR ISIBASI A LEVINE MM
Citation: C. Gonzalez et al., SALMONELLA-TYPHI VACCINE STRAIN CVD-908 EXPRESSING THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM - STRAIN CONSTRUCTION AND SAFETY AND IMMUNOGENICITY IN HUMANS, The Journal of infectious diseases, 169(4), 1994, pp. 927-931

Authors: NORIEGA FR WANG JY LOSONSKY G MANEVAL DR HONE DM LEVINE MM
Citation: Fr. Noriega et al., CONSTRUCTION AND CHARACTERIZATION OF ATTENUATED DELTA-AROA DELTA-VIRGSHIGELLA-FLEXNERI-2A STRAIN-CVD-1203, A PROTOTYPE LIVE ORAL VACCINE, Infection and immunity, 62(11), 1994, pp. 5168-5172

Authors: HOFFMAN SL EDELMAN R BRYAN JP SCHNEIDER I DAVIS J SEDEGAH M GORDON D CHURCH P GROSS M SILVERMAN C HOLLINGDALE M CLYDE D SZTEIN M LOSONSKY G PAPARELLO S JONES TR
Citation: Sl. Hoffman et al., SAFETY, IMMUNOGENICITY, AND EFFICACY OF A MALARIA SPOROZOITE VACCINE ADMINISTERED WITH MONOPHOSPHORYL LIPID A, CELL-WALL SKELETON OF MYCOBACTERIA, AND SQUALANE AS ADJUVANT, The American journal of tropical medicine and hygiene, 51(5), 1994, pp. 603-612

Authors: LAGOS R AVENDANO A HORWITZ I PRADO V FERRECCIO C SOTOMAYOR V LOSONSKY G WASSERMAN SS CRYZ S KAPER JB LEVINE MM
Citation: R. Lagos et al., TOLERANCE AND IMMUNOGENICITY OF AN ORAL D OSE OF CVD 103-HGR, A LIVE ATTENUATED VIBRIO-CHOLERAE 01 STRAIN - A DOUBLE-BLIND-STUDY IN CHILEANADULTS, Revista Medica de Chile, 121(8), 1993, pp. 857-863

Authors: TACKET CO LOSONSKY G NATARO JP CRYZ SJ EDELMAN R FASANO A MICHALSKI J KAPER JB LEVINE MM
Citation: Co. Tacket et al., SAFETY AND IMMUNOGENICITY OF LIVE ORAL CHOLERA VACCINE CANDIDATE CVD 110, A DELTA-CTXA DELTA-ZOT DELTA-ACE DERIVATIVE OF EL-TOR OGAWA VIBRIO-CHOLERAE, The Journal of infectious diseases, 168(6), 1993, pp. 1536-1540

Authors: SIMANJUNTAK CH OHANLEY P PUNJABI NH NORIEGA F PAZZAGLIA G DYKSTRA P KAY B",SUHARYONO,"BUDIARSO A RIFAI AR WASSERMAN SS LOSONSKY G KAPER J CRYZ S LEVINE MM
Citation: Ch. Simanjuntak et al., SAFETY, IMMUNOGENICITY, AND TRANSMISSIBILITY OF SINGLE-DOSE LIVE ORALCHOLERA VACCINE STRAIN CVD-103-HGR IN 24-MONTH-OLD TO 59-MONTH-OLD INDONESIAN CHILDREN, The Journal of infectious diseases, 168(5), 1993, pp. 1169-1176

Authors: EDELMAN R HOFFMAN SL DAVIS JR BEIER M SZTEIN MB LOSONSKY G HERRINGTON DA EDDY HA HOLLINGDALE MR GORDON DM CLYDE DF
Citation: R. Edelman et al., LONG-TERM PERSISTENCE OF STERILE IMMUNITY IN A VOLUNTEER IMMUNIZED WITH X-IRRADIATED PLASMODIUM-FALCIPARUM SPOROZOITES, The Journal of infectious diseases, 168(4), 1993, pp. 1066-1070

Authors: REID R BOEDEKER E BHAGAT H TACKET C LOSONSKY G NATARO J EDELMAN R LEVINE M
Citation: R. Reid et al., COLONIZATION FACTOR ANTIGEN II (CFA/II) INCORPORATED INTO BIODEGRADABLE, BIOCOMPATIBLE MICROSPHERES AS AN INTESTINAL VACCINE AGAINST ENTEROTOXIGENIC ESCHERICHIA-COLI (ETEC) - A SAFETY, IMMUNIZATION, AND EFFICACY HUMAN STUDY/, The Journal of immunology, 150(8), 1993, pp. 323-323
Risultati: 1-25 | 26-28